STASIX Trademark

Trademark Overview

On Tuesday, August 3, 2004, a trademark application was filed for STASIX with the United States Patent and Trademark Office. The USPTO has given the STASIX trademark a serial number of 78461284. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, May 22, 2015. This trademark is owned by Hemocellular Therapeutics, Inc.. The STASIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, primary hemostatic therapeutic, namely, hemostatic agents used to prevent or control bleeding
stasix

General Information

Serial Number78461284
Word MarkSTASIX
Filing DateTuesday, August 3, 2004
Status800 - REGISTERED AND RENEWED
Status DateFriday, May 22, 2015
Registration Number2998111
Registration DateTuesday, September 20, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, primary hemostatic therapeutic, namely, hemostatic agents used to prevent or control bleeding

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 12, 2004
Primary Code005
First Use Anywhere DateTuesday, May 18, 2004
First Use In Commerce DateTuesday, May 18, 2004

Trademark Owner History

Party NameENTEGRION, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameHemocellular Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27517
Party NameHemocellular Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27517
Party NameHemocellular Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27517

Trademark Events

Event DateEvent Description
Thursday, August 12, 2004NEW APPLICATION ENTERED
Monday, February 28, 2005TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2005ASSIGNED TO EXAMINER
Monday, March 7, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, March 9, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 9, 2005EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2005ASSIGNED TO LIE
Tuesday, March 15, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 8, 2005NOTICE OF PUBLICATION
Tuesday, June 28, 2005PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2005REGISTERED-PRINCIPAL REGISTER
Monday, September 12, 2011TEAS SECTION 8 RECEIVED
Wednesday, September 14, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 14, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, September 15, 2011NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, June 11, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 11, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2015TEAS SECTION 8 & 9 RECEIVED
Friday, May 22, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 22, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 22, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 22, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, July 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 6, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, June 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 23, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, June 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, June 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, June 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 20, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

stasix hemostatic namely prevent bleeding control used therapeutic preparations primary pharmaceutical